Inventor · disambiguated record
Julie Gertner-Dardenne
Also filed as: GERTNER-DARDENNE JULIE
2 granted patents·3 pending applications·0 citations·filing 2014–2024
28Inventor score
Files withSANGAMO THERAPEUTICS FRANCE3INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1INST NAT SANTE RECH MED1
Top patents by PatentIndex Score
5 records- 0159US2025092145A1Chimeric antigen receptor specific for interleukin-23 receptorSANGAMO THERAPEUTICS FRANCE·Filed 2024·Application pending·0 cites
- 0254US11981739B2Chimeric antigen receptor specific for interleukin-23 receptorSANGAMO THERAPEUTICS FRANCE·Filed 2019·Granted May 14, 2024·0 cites·20 claims
- 0352US10005839B2Antagonist of the BTLA/HVEM interaction for use in therapyINST NAT SANTE RECH MED·Filed 2014·Granted Jun 26, 2018·0 cites·4 claims
- 0444US2016122434A1Antagonist of the btla/hvem interaction for use in therapyINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2014·Application pending·0 cites
- 0538US2021292389A1New car constructs comprising tnfr2 domainsSANGAMO THERAPEUTICS FRANCE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julie Gertner-Dardenne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →